Praeparatio sicca: oritavancinum 400 mg ut oritavancini diphosphas, mannitolum, acidum phosphoricum q.s. ad pH pro vitro.
Packungsbestandteile
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Active Agent
Dose
additional_information
Oritavancinum
400 mg
Praeparatio sicca
BAG: Active Agent
Dose
Oritavancinum
400 mg
Inactive agents
Phosphoric Acid
Mannitol
Source
Data was imported : 05.05.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
